• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)——新冠病毒病(COVID-19)的病原体——的基础与临床方面的叙述性综述。

A narrative review on the basic and clinical aspects of the novel SARS-CoV-2, the etiologic agent of COVID-19.

作者信息

Hokello Joseph, Sharma Adhikarimayum Lakhikumar, Shukla Girish C, Tyagi Mudit

机构信息

Department of Basic Science, Faculty of Science and Technology, Kampala International University-Western Campus, P.O Box 71, Bushenyi, Uganda.

Center for Translational Medicine, Thomas Jefferson University, Philadelphia, PA, USA.

出版信息

Ann Transl Med. 2020 Dec;8(24):1686. doi: 10.21037/atm-20-5272.

DOI:10.21037/atm-20-5272
PMID:33490198
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7812224/
Abstract

The novel SARS-CoV-2 is responsible for causing the ongoing outbreak of coronavirus disease 19 (COVID-19), a systemic infection in humans. Ever since it was first detected in December 2019, the number of confirmed cases has continued to increase. Within a short period, this disease has become a global issue, and therefore it is characterized as a pandemic. The current understanding and explanations are based on epidemiological, clinical and physiological observations. Besides, it remains a great challenge, as much remains to be understood about this new disease-causing virus. Therefore, we seek to provide an overview of SARS-CoV-2, including its classification, origin, genomic structure, replication cycle, transmission, pathogenesis, clinical aspects, diagnosis, treatments, prevention and vaccine options. We conducted a literature search for the articles published up to August 2020 using the keywords 'SAR-CoV-2' and 'COVID19' in medical databases; PubMed, google scholar, EMBASE, and web of science. Based on the information collected, the emerging COVID-19, caused by SARS-CoV-2, exhibits strong infectivity but less virulence in terms of severity of disease and mortality rates in certain age groups. It inflicts more damage in terms of peoples' health and well-being, social life, and global economic impacts. Unfortunately, there is no adequate global and standard response to this pandemic to date, and each country is facing a crisis based on its situation, expertise, and hypotheses. While there is no effective therapy and vaccine against the novel SARS-CoV-2 yet, preventive measures are the only tool available to our disposal to control the spread of the COVID-19 pandemic. Ongoing and future research is focused more on developing standard treatment strategies, and efficacious vaccines, which would be useful to tackle this pandemic globally.

摘要

新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)导致了目前正在爆发的冠状病毒病19(COVID-19),这是一种人类全身性感染疾病。自2019年12月首次检测到该病毒以来,确诊病例数量持续增加。在短时间内,这种疾病已成为一个全球性问题,因此被定性为大流行病。目前的理解和解释基于流行病学、临床和生理学观察。此外,这仍然是一个巨大的挑战,因为对于这种新型致病病毒仍有许多有待了解之处。因此,我们试图概述SARS-CoV-2,包括其分类、起源、基因组结构、复制周期、传播、发病机制、临床方面、诊断、治疗、预防和疫苗选择。我们使用医学数据库(PubMed、谷歌学术、EMBASE和科学网)中的关键词“SAR-CoV-2”和“COVID19”对截至2020年8月发表的文章进行了文献检索。根据收集到的信息,由SARS-CoV-导致的新出现的COVID-19具有很强的传染性,但就某些年龄组的疾病严重程度和死亡率而言,其毒力较低。它在人们的健康和福祉、社会生活以及全球经济影响方面造成了更大的破坏。不幸的是,迄今为止,全球对这一大流行病没有充分的、标准的应对措施,每个国家都根据自身情况、专业知识和假设面临着危机。虽然目前还没有针对新型SARS-CoV-2的有效治疗方法和疫苗,但预防措施是我们可用来控制COVID-19大流行传播的唯一手段。正在进行的和未来的研究更多地集中在制定标准治疗策略和有效的疫苗,这将有助于在全球应对这一大流行病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d7/7812224/bae4a47eafae/atm-08-24-1686-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d7/7812224/64d4dac5c571/atm-08-24-1686-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d7/7812224/1b513a767976/atm-08-24-1686-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d7/7812224/db5e430a6035/atm-08-24-1686-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d7/7812224/bae4a47eafae/atm-08-24-1686-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d7/7812224/64d4dac5c571/atm-08-24-1686-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d7/7812224/1b513a767976/atm-08-24-1686-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d7/7812224/db5e430a6035/atm-08-24-1686-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d7/7812224/bae4a47eafae/atm-08-24-1686-f4.jpg

相似文献

1
A narrative review on the basic and clinical aspects of the novel SARS-CoV-2, the etiologic agent of COVID-19.关于新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)——新冠病毒病(COVID-19)的病原体——的基础与临床方面的叙述性综述。
Ann Transl Med. 2020 Dec;8(24):1686. doi: 10.21037/atm-20-5272.
2
COVID-19: a conundrum to decipher.COVID-19:一个待破译的谜。
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378.
3
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
4
The Coronavirus Pandemic: What Does the Evidence Show?新冠疫情:证据表明了什么?
J Nepal Health Res Counc. 2020 Apr 19;18(1):1-9. doi: 10.33314/jnhrc.v18i1.2596.
5
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗:辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
6
The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.疫情初期防控措施下新型冠状病毒在中国的空间传播。
Arch Public Health. 2021 Jan 13;79(1):8. doi: 10.1186/s13690-021-00529-z.
7
Systematic Review of Clinical Insights into Novel Coronavirus (CoVID-19) Pandemic: Persisting Challenges in U.S. Rural Population.新型冠状病毒(COVID-19)大流行的临床洞察系统评价:美国农村人口的持续挑战。
Int J Environ Res Public Health. 2020 Jun 15;17(12):4279. doi: 10.3390/ijerph17124279.
8
Covid-19 Pandemic: Through the Lens of Science, a Painstaking Review.《新冠疫情:透过科学视角的详尽审视》
Clin Lab. 2020 Oct 1;66(10). doi: 10.7754/Clin.Lab.2020.200642.
9
Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development.中东呼吸综合征、严重急性呼吸综合征冠状病毒和严重急性呼吸综合征冠状病毒2的比较与对比:预防、传播、管理及疫苗研发
Pathogens. 2020 Nov 26;9(12):985. doi: 10.3390/pathogens9120985.
10
An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.关于在疫情爆发情况下治疗新型冠状病毒(SARS-CoV-2)的新兴治疗和预防策略的循证系统评价。
J Basic Clin Physiol Pharmacol. 2020 Sep 14;31(6):jbcpp-2020-0113. doi: 10.1515/jbcpp-2020-0113.

引用本文的文献

1
Evidence of SARS-CoV-2 infection in gallbladder and aggravating cholecystitis to septic shock: a case report.胆囊中新型冠状病毒2019感染证据及胆囊炎加重致感染性休克:一例报告
Ann Transl Med. 2021 Nov;9(21):1631. doi: 10.21037/atm-21-4778.
2
A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis.CD47/SIRPα 轴在 COVID-19 发病机制中的潜在作用。
Curr Issues Mol Biol. 2021 Sep 22;43(3):1212-1225. doi: 10.3390/cimb43030086.
3
The Management of Acute Colonic Diverticulitis in the COVID-19 Era: A Scoping Review.新冠疫情时代急性结肠憩室炎的管理:一项范围综述

本文引用的文献

1
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19).COVID-19 住院患者使用羟氯喹(无论是否联合使用阿奇霉素)导致 QT 间期延长的风险。
JAMA Cardiol. 2020 Sep 1;5(9):1036-1041. doi: 10.1001/jamacardio.2020.1834.
2
Immunopathogenesis of COVID-19 and early immunomodulators.新型冠状病毒肺炎的免疫发病机制及早期免疫调节剂
Clin Exp Pediatr. 2020 Jul;63(7):239-250. doi: 10.3345/cep.2020.00759. Epub 2020 Jun 18.
3
Pulse Therapy With Corticosteroids and Intravenous Immunoglobulin in the Management of Severe Tocilizumab-Resistant COVID-19: A Report of Three Clinical Cases.
Medicina (Kaunas). 2021 Oct 18;57(10):1127. doi: 10.3390/medicina57101127.
4
Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy.以戊糖磷酸途径为靶点进行新冠病毒治疗。
Metabolites. 2021 Oct 13;11(10):699. doi: 10.3390/metabo11100699.
皮质类固醇与静脉注射免疫球蛋白脉冲疗法治疗重度托珠单抗耐药的COVID-19:三例临床病例报告
Cureus. 2020 Jul 7;12(7):e9038. doi: 10.7759/cureus.9038.
4
Cardiac manifestations in COVID-19 patients-A systematic review.新冠病毒感染患者的心脏表现——一项系统综述
J Card Surg. 2020 Aug;35(8):1988-2008. doi: 10.1111/jocs.14808. Epub 2020 Jul 11.
5
Transmission of SARS-CoV-2 via fecal-oral and aerosols-borne routes: Environmental dynamics and implications for wastewater management in underprivileged societies.SARS-CoV-2 通过粪口和空气传播途径传播:环境动态及其对贫困社会中废水管理的影响。
Sci Total Environ. 2020 Nov 15;743:140709. doi: 10.1016/j.scitotenv.2020.140709. Epub 2020 Jul 3.
6
The optimal diagnostic methods for COVID-19.新型冠状病毒肺炎的最佳诊断方法。
Diagnosis (Berl). 2020 Nov 18;7(4):349-356. doi: 10.1515/dx-2020-0058.
7
Diagnostic impact of bedside chest X-ray features of 2019 novel coronavirus in the routine admission at the emergency department: case series from Lombardy region.2019 年新型冠状病毒在急诊科常规入院时床边胸部 X 线特征的诊断影响:来自伦巴第地区的病例系列。
Eur J Radiol. 2020 Aug;129:109092. doi: 10.1016/j.ejrad.2020.109092. Epub 2020 May 26.
8
Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.雅培 ID Now COVID-19 快速核酸扩增检测试剂使用鼻咽拭子和干鼻拭子在纽约市学术机构中运输的病毒运输介质的性能。
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01136-20.
9
Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City.纽约市一家三级保健医疗中心的住院和重症 2019 冠状病毒病患儿和青少年的临床特征和结局。
J Pediatr. 2020 Aug;223:14-19.e2. doi: 10.1016/j.jpeds.2020.05.006. Epub 2020 May 11.
10
A strategic approach to COVID-19 vaccine R&D.一种应对新冠病毒疫苗研发的战略方法。
Science. 2020 May 29;368(6494):948-950. doi: 10.1126/science.abc5312. Epub 2020 May 11.